Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Saxagliptin
Study Title: This study was done to learn how saxagliptin
worked and about its safety in participants
with type 2 diabetes mellitus who also
have heart failure
Protocol Number: D1680C00016
Thank you!
Thank you for taking part in the clinical study for the study drug saxagliptin.
You and all of the participants helped researchers learn more about saxagliptin to help people
with type 2 diabetes mellitus and heart failure. Type 2 diabetes mellitus is also called T2DM.
AstraZeneca AB sponsored this study and believes it is important to share the results of the
study with you and the public. An independent non-profit organization called CISCRP helped
prepare this summary of the study results for you. We hope it helps you understand and feel
proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.
1